# Clorox Co. (CLX)

- Sector: Consumer Staples · Industry: Household and Personal Products
- SEC CIK: 0000021076 ([filings on EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000021076))
- Full page: https://inspectstocks.com/stocks/clx
- Data as of: price 2026-09-28; newest filing used 2026-04-30; latest fiscal period ended 2026-03-31

## Grade

**F+** on the growth-and-cash rubric, 1 of 5 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Revenue growing overall | failed | $6.8B | $7.2B |
| Revenue growing recently | failed | $6.8B | $7.1B |
| Free cash flow positive | passed | $380M |  |
| Free cash flow growing overall | failed | $380M | $840M |
| Free cash flow growing recently | failed | $380M | $761M |

Business quality (the + / − mark): 4 of 5 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | passed | 11.2% |  |
| Healthy profit margin | passed | 11.2% |  |
| Good return on equity | passed | 235.5% |  |
| Debt under control | failed | 9.08 |  |
| Turns sales into cash | passed | 5.6% |  |

How the grade works: the letter counts failed checks (none → A, one → B, two → C, three → D, four or more → F). It is built from SEC filings only — the share price never enters it — and describes the business, not whether the stock is worth buying.

## Key figures

In US dollars, as filed.

| Measure | Value |
| --- | --- |
| Revenue, trailing twelve months | $6.8B |
| Net income, trailing twelve months | $756M |
| Free cash flow, trailing twelve months | $380M |
| Net margin | 11.2% |
| Return on equity | 235.5% |
| Debt to equity | 9.08 |
| Diluted EPS, trailing twelve months | $6.16 |
| Share price | $81.41 |
| Market value | $9.8B |
| Price / earnings | 13.2x |
| Price / sales | 1.5x |

## More on this company

- [Overview](https://inspectstocks.com/stocks/clx)
- [Financial statements](https://inspectstocks.com/stocks/clx/financials)
- [Competitors](https://inspectstocks.com/stocks/clx/peers)
- [Earnings](https://inspectstocks.com/stocks/clx/earnings)

---

Source: InspectStocks, built from the company’s own SEC filings. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.